Trevi Therapeutics (NASDAQ:TRVI) Given New $20.00 Price Target at Oppenheimer
Trevi Therapeutics (NASDAQ:TRVI – Free Report) had its price target increased by Oppenheimer from $12.00 to $20.00 in a research report report published on Tuesday,Benzinga reports. Oppenheimer currently has an outperform rating on the stock. A number of other brokerages have also issued reports on TRVI. Needham & Company LLC raised their target price on […]
More Stories
Russia Bans Producers From Exporting Gasoline
By Guy Birchall Russia extended a temporary ban on gasoline exports to producers, Moscow said on April 2, citing the...
Who is Tiger Woods? Age, Marriage, Children, and Recent Controversy
Tiger Woods is one of the most famous American golfers. He is known as one of the greatest golf players...
Oil Falls, Stocks Jump on Renewed Hopes of Iran War Ending
By Tom Ozimek Oil prices dropped and stocks around the world rallied on April 1 on renewed hopes of a...
US Appeals Court Blocks Judge’s Rulings Against Trump Immigration Detention Policy
By Jack Phillips A U.S. appeals court on Tuesday halted a federal judge’s nationwide rulings that blocked the Trump administration...
Trump Says He’s Strongly Considering Pulling US Out of NATO
By Guy Birchall U.S. President Donald Trump said he is strongly considering withdrawing the United States from NATO, in comments...
Iran’s Top Leader Issues Statement Saying Regime Will Keep Backing Anti-Israel Forces
By Jack Phillips Iran’s top leader released a new statement on April 1 saying the Iranian regime will continue to...